AI assistant
CONMED Corp — Director's Dealing 2021
Feb 19, 2021
31971_dirs_2021-02-19_a39e622b-01db-48ce-b4db-767a6462f196.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2021-02-18
Reporting Person: Hartman Curt R (Director, President, CEO and Chair)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-18 | Common Stock | S | 11900 | $119.73 | Disposed | 125957 | Direct |
| 2021-02-18 | Common Stock | S | 3100 | $120.68 | Disposed | 122857 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.00 to $119.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.10 to $121.00. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.